Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05222165
Title Study With Infigratinib in Subjects With Advanced Solid and CNS Tumors or Recurrent or Progressive Low-Grade Glioma With Selected FGFR1-3 Alterations (NEWEL)
Acronym NEWEL
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Helsinn Healthcare SA
Indications
Therapies
Age Groups: adult | child | senior
Covered Countries USA | DEU | CAN

Facility Status City State Zip Country Details
Lucile Packard Children's Hospital at Stanford University Medical Center Palo Alto California 94304 United States Details
Children's National Hospital - Brain Tumor Institute Washington District of Columbia 20010-2916 United States Details
Nicklaus Children's Hospital Miami Florida 33155 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke Cancer Institute (DCI) - The Preston Robert Tisch Brain Tumor Center Durham North Carolina 27702-3624 United States Details
UPCM - Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224-1529 United States Details
University of Alberta - Stollery Children's Hospital (SCH) Edmonton Alberta T6G 2B7 Canada Details
McMaster Children's Hospital (MCH) Hamilton Ontario L8N 3Z5 Canada Details
University of Toronto - The Hospital for Sick Children (SickKids) Toronto Ontario M5G 1X8 Canada Details
Universitaetsklinikum Heidelberg (UKHD) - Zentrum fuer Kinder- und Jugendmedizin - Klinik Kinderheilkunde III Heidelberg Baden-Wuerttemberg 69120 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field